IP Verse

Teva Pharmaceuticals USA, Inc v. Bayer Pharma AG et al. - IPR2022-01513

Explore the PTAB proceeding IPR2022-01513 filed by Teva Pharmaceuticals USA, Inc against Bayer Pharma AG et al. on Sep 9, 2022. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2022-01513
Filing Date
Sep 9, 2022
Petitioner
Teva Pharmaceuticals USA, Inc
Respondent
Bayer Pharma AG et al.
Status
Terminated-Adverse Judgment
Respondent Application Number
16264032
Respondent Tech Center
1600
Respondent Patent Number
10828310
Institution Decision Date
Oct 19, 2022
Termination Date
Jan 12, 2026

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2022-01513.

TypeName
Petitioner CounselVira, Chandrikaet al
Respondent CounselGrossman, Dovet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.